Phosphorescent emitters containing dibenzo[1,4]azaborinine structure

US9231218B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9231218-B2
Application numberUS-201313798935-A
CountryUS
Kind codeB2
Filing dateMar 13, 2013
Priority dateJul 10, 2012
Publication dateJan 5, 2016
Grant dateJan 5, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A dibenzo[1,4]azaborine comprising compound, and devices and formulations including the same are described. The compound includes a ligand L 1 including wherein E 1 is N; E 2 is B; and R 3 and R 4 represent mono, di, tri, tetra substitutions or no substitution; wherein R 1 , R 2 , R 3 and R 4 are each independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein any two adjacent R 1 , R 2 , R 3 , and R 4 are optionally joined to form a ring, which may be further substituted; wherein L 1 is coordinated to a metal M, provided that the metal M does not form bond with E 1 and E 2 ; and wherein L 1 may be linked with other ligands to comprise a bidentate, tridentate, tetradentate, pentadentate or hexadentate ligand.

First claim

Opening claim text (preview).

We claim: 1. A compound comprising a first ligand L 1 ; wherein L 1 comprises the following formula: wherein E 1 is N; wherein E 2 is B; wherein R 3 and R 4 represent mono, di, tri, tetra substitutions or no substitution; wherein R 1 , R 2 , R 3 and R 4 are each independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein any two adjacent R 1 , R 2 , R 3 , and R 4 are optionally joined to form a ring, which may be further substituted; wherein (i) at least one R 1 , R 2 , R 3 , or R 4 is a 5-or 6-membered heteroaryl ring A containing a nitrogen, (ii) at least one pair of adjacent substituents R 1 , R 2 , R 3 , and R 4 form a fused ring B that includes E 1 or E 2 , or (iii) both (i) and (ii); wherein ring A, ring B, or both ring A and ring B are coordinated to metal M; wherein ring A and ring B can be further substituted; wherein L 1 is coordinated to a metal M, provided that the metal M does not form bond with E 1 and E 2 ; and wherein L 1 may be linked with other ligands to comprise a bidentate, tridentate, tetradentate, pentadentate or hexadentate ligand. 2. The compound of claim 1 , wherein the metal M is a metal selected from the group consisting of Ir, Pt, Re, Os, Ru, Rh, Pd, Cu, Ag, and Au. 3. The compound of claim 1 , wherein the metal M is Ir. 4. The compound of claim 1 , wherein the metal M is Pt. 5. The compound of claim 1 , wherein at least one of R 1 and R 2 is aryl or substituted aryl. 6. The compound of claim 5 , wherein at least one of R 1 and R 2 is phenyl, or 2,6-disubstituted phenyl. 7. The compound of claim 1 , wherein the compound is homoleptic. 8. The compound of claim 1 , wherein the compound is heteroleptic. 9. The compound of claim 8 , wherein the compound comprises a second ligand L 2 ; wherein the ligand L 2 or part of the ligand L 2 if the ligand is more than bidentate is selected from the group consisting of: wherein R a , R b , R c , and R d may represent mono, di, tri, or tetra substitution, or no substitution; wherein R a , R b , R c , and R d are independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein two adjacent substituents of R a , R b , R c , and R d are optionally joined to form a fused ring or form a multidentate ligand. 10. The compound of claim 1 , wherein the compound having the formula: wherein L 2 is a second ligand coordinated to the metal M; wherein each L 2 can be same or different; wherein m is a value from 1 to the maximum number of ligands that may be attached to the metal M; wherein m+n is the maximum number of ligands that may be attached to the metal M; and wherein any of R 1 , R 2 , and R 3 are optionally linked to L 2 to comprise a bidentate, tridentate, tetradentate, pentadentate or hexadentate ligand. 11. The compound of claim 10 , wherein at least one of R 1 , R 2 , and R 3 are linked to L 2 to comprise a bidentate, tridentate, tetradentate, pentadentate or hexadentate ligand. 12. The compound of claim 10 , wherein the compound is selected from the group consisting of: wherein X 1 , X 2 is selected from the group consisting of C, N, O, P, S, and B; wherein A is a 5-membered or 6-membered carbocyclic or heterocyclic ring; wherein R 5 represents mono, di, tri, tetra substitutions or no substitution; wherein R 5 is selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein any two adjacent R 1 , R 2 , R 3 , R 4 , and R 5 are optionally joined to form a ring, which may be further substituted. 13. The compound of claim 12 , wherein A is selected from the group consisting of: wherein Y is selected from the group consisting of BR, NR, PR, O, S, Se, C═O, S═O, SO 2 , CRR′, SiRR′, and GeRR′; wherein R, R′ are independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein R, R′ are optionally joined to form a ring with any adjacent substituent. 14. The compound of claim 10 , wherein the compound is selected from the group consisting of: 15. The compound of claim 14 , wherein m is 3, and n is 0. 16. The compound of claim 14 , wherein m is 1, and n is 2. 17. The compound of claim 14 , wherein L 2 is selected from the group consisting of: 18. The compound of claim 10 , wherein the compound is selected from the group consisting of:

Assignees

Inventors

Classifications

  • Organoboranes · CPC title

  • comprising platinum · CPC title

  • C09K11/06Primary

    containing organic luminescent materials · CPC title

  • characterised by the chemical or physical composition or the arrangement of the electroluminescent material {, or by the simultaneous addition of the electroluminescent material in or onto the light source} · CPC title

  • containing one nitrogen atom as the heteroatom · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9231218B2 cover?
A dibenzo[1,4]azaborine comprising compound, and devices and formulations including the same are described. The compound includes a ligand L 1 including wherein E 1 is N; E 2 is B; and R 3 and R 4 represent mono, di, tri, tetra substitutions or no substitution; …
Who is the assignee on this patent?
Universal Display Corp
What technology area does this patent fall under?
Primary CPC classification C09K11/06. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).